Form 4: OPKO Health Director Paganelli Acquires Stock Options
SEC Form 4 Filing
Director John A. Paganelli of OPKO Health, Inc. acquired stock options exercisable for 30,000 shares of common stock.
Summary
- On March 28, 2024, John A. Paganelli, a director of OPKO Health, Inc., acquired stock options.
- These options grant the right to buy 30,000 shares of OPKO Health's common stock.
- The exercise price of the options is $1.20.
- The options become exercisable on March 28, 2025, and expire on March 27, 2034.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, indicating a neutral sentiment. It simply reports a transaction.
Industry Context
Form 4 filings are routine disclosures of transactions by company insiders and provide transparency to the market.
Stakeholder Impact
- The acquisition of stock options by a director could be perceived positively by shareholders, aligning management's interests with theirs.
Key Dates
| Date | Description |
|---|---|
| 03/28/2024 | Date of transaction: Director Paganelli acquired stock options. |
| 03/28/2025 | Date the stock options become exercisable. |
| 03/27/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.